Healthcare Services

Isosorbide Mononitrate Tablet Market Forecast Analysis Through 2030 With Insights On Industry Expansion

June 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Isosorbide Mononitrate Tablet Market Change Between 2026 And 2030?

The isosorbide mononitrate tablet market has demonstrated robust growth in recent years. It is forecast to grow from $1.2 billion in 2025 to $1.26 billion in 2026, with a compound annual growth rate (CAGR) of 5.3%. This expansion in the historical period can be attributed to the rising prevalence of coronary artery disease, the long-term use of nitrates in angina management, an increasing aging population, the availability of cost-effective generic drugs, and the expansion of hospital and retail pharmacy infrastructure.

The isosorbide mononitrate tablet market is anticipated to experience robust expansion in the coming years. By 2030, this market is projected to reach $1.55 billion, demonstrating a compound annual growth rate (CAGR) of 5.3%. Key drivers for this growth during the forecast period include the rise in chronic cardiovascular ailments, a greater need for extended-release tablets, the increasing use of online pharmacies, enhanced diagnosis of angina and heart failure, and broader availability of cardiovascular medications in developing regions. Significant trends anticipated within this period involve the development of long-acting cardiovascular maintenance treatments, an increasing inclination towards extended-release formulations, the wider adoption of generic nitrate drugs, better patient compliance due to once-daily dosing regimens, and expanded availability through online and traditional retail pharmacies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24268&type=smp

Which Growth Factors Are Strengthening The Isosorbide Mononitrate Tablet Market Landscape?

The growing incidence of cardiovascular diseases is projected to drive the expansion of the isosorbide mononitrate tablet market. Cardiovascular diseases (CVDs) are a group of conditions impacting the heart and blood vessels, including coronary artery disease, heart failure, and hypertension. The increasing prevalence of these diseases is primarily linked to unhealthy diets, often high in saturated fats, trans fats, sodium, and added sugars, which can lead to conditions like obesity, hypertension, and high cholesterol. Isosorbide mononitrate tablets assist in managing cardiovascular diseases by dilating and relaxing blood vessels, thereby improving blood flow and reducing the heart’s workload. This action helps to alleviate chest pain (angina), lower blood pressure, and enhance oxygen delivery to the heart muscle. For example, in September 2025, a report from the Global Burden of Disease study, as cited by the American College of Cardiology, a US-based nonprofit medical association and professional society for cardiologists, indicated 19.2 million cardiovascular disease deaths globally in 2023. Hence, the rising occurrence of cardiovascular diseases is significantly boosting the isosorbide mononitrate tablet market.

Which Segment-Based Categories Are Covered In The Isosorbide Mononitrate Tablet Market?

The isosorbide mononitrate tablet market covered in this report is segmented –

1) By Dosage Form: Immediate-Release Tablets, Extended-Release Tablets

2) By Indication Type: Angina Pectoris, Coronary Artery Disease (CAD)

3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Immediate-Release Tablets: Low-Dose, Single Strength Tablets

2) By Extended-Release Tablets: Moderate-Dose, High-Dose, Once-Daily Formulation, Twice-Daily Formulation

Which Trends Are Influencing The Direction Of The Isosorbide Mononitrate Tablet Market?

Major companies within the isosorbide mononitrate tablet market are concentrating on developing innovative products, such as extended-release (ER) formulations, to improve patient adherence, provide prolonged therapeutic effects, and optimize treatment outcomes for conditions like angina pectoris. An extended-release formulation is an advanced drug delivery system that facilitates the gradual release of medication over an extended period, thereby reducing the frequency of dosing and maintaining consistent blood levels. For instance, in February 2024, Zydus Lifesciences Limited, an India-based pharmaceutical manufacturing company, received approval from the United States Food and Drug Administration (USFDA) to manufacture and market isosorbide mononitrate extended-release tablets USP in strengths of 30 mg, 60 mg, and 120 mg. These tablets are prescribed to prevent chest pain (angina) in patients with coronary artery disease and are equivalent to the reference listed drug (RLD), imdur extended-release tablets.

Who Are The Businesses Driving Activity In The Isosorbide Mononitrate Tablet Market?

Major companies operating in the isosorbide mononitrate tablet market are Pfizer Inc., Merck & Co., Inc., AstraZeneca plc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Zydus Lifesciences Limited, Torrent Pharmaceuticals Ltd., Micro Labs Ltd., Lupin Limited, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Alkem Laboratories Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Sandoz International GmbH, Qilu Pharmaceutical Co., Ltd., Lunan Pharmaceutical Group, Shandong Keyuan Pharmaceutical Co., Ltd.

Access The Complete Isosorbide Mononitrate Tablet Market Report:

https://www.thebusinessresearchcompany.com/report/isosorbide-mononitrate-tablet-global-market-report

Which Region Leads The Isosorbide Mononitrate Tablet Market By Size?

North America was the largest region in the isosorbide mononitrate tablet market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the isosorbide mononitrate tablet market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Isosorbide Mononitrate Tablet Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=24268&type=smp

Browse Through More Reports Similar to the Global Isosorbide Mononitrate Tablet Market 2026, By The Business Research Company

Effervescent Tablet Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/effervescent-tablet-global-market-report

Tablets Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/tablets-global-market-report

Isoprene Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/isoprene-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795